A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)
Clinical trial NCT01710501 · COMPLETED
Trial details
- NCT number
- NCT01710501
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-07
- Primary completion
- 2013-11-25
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.